Residual Tumor Burden After Immunotherapy Predicts Survival in Esophageal Cancer
A real-world study of 178 esophageal cancer patients shows that residual tumor grade and post-treatment lymph node status, especially ypN3, ...
A real-world study of 178 esophageal cancer patients shows that residual tumor grade and post-treatment lymph node status, especially ypN3, ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.